Kobbe G - Search Results

1

A prospective non-interventional study on the impact of transfusion burden and related iron toxicity on outcome in myelodysplastic syndromes undergoing allogeneic hematopoietic cell transplantation.

Cremers EMP, de Witte T, de Wreede L, Eikema DJ, Koster L, van Biezen A, Finke J, Socié G, Beelen D, Maertens J, Nagler A, Kobbe G, Ziagkos D, Itälä-Remes M, Gedde-Dahl T, Sierra J, Niederwieser D, Ljungman P, Beguin Y, Ozkurt ZN, Anagnostopoulos A, Jindra P, Robin M, Kröger N. Cremers EMP, et al. Among authors: kobbe g. Leuk Lymphoma. 2019 Oct;60(10):2404-2414. doi: 10.1080/10428194.2019.1594215. Epub 2019 Apr 18. Leuk Lymphoma. 2019. PMID: 30997844 Free article.

2

[Role of aggressive treatment strategies for myelodysplastic syndromes].

Aul C, Germing U, Minning H, Kobbe G, Gattermann N, Südhoff T, Meckenstock G, Söhngen D, Heyll A. Aul C, et al. Among authors: kobbe g. Praxis (Bern 1994). 1999 Mar 4;88(10):431-8. Praxis (Bern 1994). 1999. PMID: 10199215 Review. German.

3

Reliable engraftment, low toxicity, and durable remissions following allogeneic blood stem cell transplantation with minimal conditioning.

Kobbe G, Schneider P, Aivado M, Zohren F, Schubert D, Fenk R, Neumann F, Kronenwett R, Pape H, Rong A, Royer-Pokora B, Hildebrandt B, Germing U, Gattermann N, Heyll A, Haas R. Kobbe G, et al. Exp Hematol. 2002 Nov;30(11):1346-53. doi: 10.1016/s0301-472x(02)00923-2. Exp Hematol. 2002. PMID: 12423689 Free article.

4

Transplantation of allogeneic CD34+-selected cells followed by early T-cell add-backs: favorable results in acute and chronic myeloid leukemia.

Kobbe G, Fenk R, Neumann F, Bernhardt A, Steidl U, Kondakci M, Graef T, Aivado M, Vaupel M, Huenerlituerkoglu AN, Kronenwett R, Pape H, Hildebrand B, Germing U, Haas R. Kobbe G, et al. Cytotherapy. 2004;6(6):533-42. doi: 10.1080/14653240410005375. Cytotherapy. 2004. PMID: 15764020

5

The ratio between CD4+ and CD8+ cells in the peripheral blood of patients with hematological malignancies is not altered by thalidomide.

Strupp C, Germing U, Aivado M, Kündgen A, Fenk R, Hünerlitürkoglu A, Kobbe G, Haas R, Gattermann N. Strupp C, et al. Among authors: kobbe g. Leuk Lymphoma. 2005 Jul;46(7):999-1006. doi: 10.1080/10428190500078300. Leuk Lymphoma. 2005. PMID: 16019550

6

Successful treatment of relapsed AML after allogeneic stem cell transplantation with azacitidine.

Graef T, Kuendgen A, Fenk R, Zohren F, Haas R, Kobbe G. Graef T, et al. Among authors: kobbe g. Leuk Res. 2007 Feb;31(2):257-9. doi: 10.1016/j.leukres.2006.03.003. Epub 2006 Apr 18. Leuk Res. 2007. PMID: 16620971

7

Monitoring of the JAK2-V617F mutation by highly sensitive quantitative real-time PCR after allogeneic stem cell transplantation in patients with myelofibrosis.

Kröger N, Badbaran A, Holler E, Hahn J, Kobbe G, Bornhäuser M, Reiter A, Zabelina T, Zander AR, Fehse B. Kröger N, et al. Among authors: kobbe g. Blood. 2007 Feb 1;109(3):1316-21. doi: 10.1182/blood-2006-08-039909. Epub 2006 Oct 3. Blood. 2007. PMID: 17018857 Free article.

8

HLA-identical sibling allogeneic peripheral blood stem cell transplantation with reduced intensity conditioning compared to autologous peripheral blood stem cell transplantation for elderly patients with de novo acute myeloid leukemia.

Herr AL, Labopin M, Blaise D, Milpied N, Potter M, Michallet M, Heit W, Ferrara F, Esteve J, Arcese W, Ehninger G, Rowe JM, Kobbe G, Rosselet A, Bunjes D, Rio B, Brune M, Nagler A, Gorin NC, Frassoni F, Rocha V; Acute Leukemia Working Party or the European Group for Blood and Marrow Transplantation. Herr AL, et al. Among authors: kobbe g. Leukemia. 2007 Jan;21(1):129-35. doi: 10.1038/sj.leu.2404461. Epub 2006 Nov 23. Leukemia. 2007. PMID: 17128198

9

Prognostic factors for patients with acute myeloid leukaemia or high-risk myelodysplastic syndromes undergoing myeloablative or non-myeloablative allogeneic blood stem cell transplantation.

Graef T, Vaupel M, Fenk R, Ruf L, Zohren F, Germing U, Haas R, Kobbe G. Graef T, et al. Among authors: kobbe g. Hematol Oncol. 2007 Dec;25(4):170-7. doi: 10.1002/hon.823. Hematol Oncol. 2007. PMID: 17579887

10

Rapid regression of bone marrow fibrosis after dose-reduced allogeneic stem cell transplantation in patients with primary myelofibrosis.

Kröger N, Thiele J, Zander A, Schwerdtfeger R, Kobbe G, Bornhäuser M, Bethge W, Schubert J, de Witte T, Kvasnicka HM; MDS-Subcommittee of the Chronic Leukaemia Working Party of the European Group for Blood and Marrow Transplantation. Kröger N, et al. Among authors: kobbe g. Exp Hematol. 2007 Nov;35(11):1719-22. doi: 10.1016/j.exphem.2007.08.022. Exp Hematol. 2007. PMID: 17976523 Free article. Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

250 results

Search Page